Angiotensin-converting enzyme inhibition reverses luteal phase steroid production in oocyte donors**Presented at the Conjoint Meeting of The American Fertility Society and the Canadian Fertility and Andrology Society, October 11 to 14, 1993, Montreal, Quebec, Canada.
- 1 April 1995
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 63 (4), 854-858
- https://doi.org/10.1016/s0015-0282(16)57493-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Ovarian derived prorenin-angiotensin cascade in human reproductionFertility and Sterility, 1994
- Effect of angiotensin II on human luteinized granulosa cellsFertility and Sterility, 1993
- Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatmentFertility and Sterility, 1992
- Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathyAlbrecht von Graefes Archiv für Ophthalmologie, 1990
- Establishment of a nonanonymous donor oocyte program: preliminary experience at the University of Southern CaliforniaFertility and Sterility, 1989
- Angiotensin II Receptors in the GonadsAmerican Journal of Hypertension, 1989
- Angiotensin converting enzyme inhibition with a low dose of enalapril in normotensive diabetics with persistent proteinuriaJournal Of Hypertension, 1988
- Blockage of Ovulation by an Angiotensin AntagonistScience, 1988
- Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndromeFertility and Sterility, 1987
- Effects of Angiotensin II and Some Analogues on Vascular Permeability in the RabbitCirculation Research, 1972